1.
Stratifying Cardiovascular–Kidney–Metabolic Syndrome by Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pathophysiology-Anchored, India-Contextualised Framework for Node-Directed Pharmacotherapy. d. 2026;5(1):1-23. Accessed July 28, 2026. https://thediabzen.com/index.php/d/article/view/40